The artificial corneal implants market size was estimated at US$ 67.95 million in 2022 it is predicted to grow at a CAGR of 7.16% from 2023 to 2032 to reach around US$ 135.68 million by the end of 2032.
The artificial corneal implants market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global artificial corneal implants market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global artificial corneal implants market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/39986
Artificial Corneal Implants Market Key Players and Regions Segmentations:
| Key Players | Regions |
| FCI Ophthalmics, Inc.
Beijing Microkpro Medical Instrument Co. Ltd. DIOPTEX Medizinprodukte Forschungs KeraMed, Inc. EyeYon |
North America
Europe Asia Pacific Latin America Middle East & Africa |
This study covers an elaborate segmentation of the global artificial corneal implants market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global artificial corneal implants market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Artificial Corneal Implants Market Segmentations:
By Transplant Type
- Hard Keratoprosthesis
- Boston Kpro
- Osteo-Odonto-Keratoprosthesis
- Soft Keratoprosthesis
By Indication
- Stevens-Johnson syndrome (SJS)
- Ocular Cicatricial Pemphigoid (OCP)
- Ocular burns
- Keratoconus
- Corneal stromal dystrophies
- Others
By Implant Type
- Synthetic
- Biosynthetic
By Implant End-use
- Hospitals
- Ophthalmic Centers
- Ambulatory Surgical Centers
Research Methodology
The research methodology acquire by analysts for assemble the global artificial corneal implants market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global artificial corneal implants market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Artificial Corneal Implants Market
5.1. COVID-19 Landscape: Artificial Corneal Implants Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Artificial Corneal Implants Market, By Transplant Type
8.1. Artificial Corneal Implants Market, by Transplant Type, 2023-2032
8.1.1. Hard Keratoprosthesis
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Soft Keratoprosthesis
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Artificial Corneal Implants Market, By Indication
9.1. Artificial Corneal Implants Market, by Indication, 2023-2032
9.1.1. Stevens-Johnson syndrome (SJS)
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Ocular Cicatricial Pemphigoid (OCP)
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Ocular burns
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. Keratoconus
9.1.4.1. Market Revenue and Forecast (2019-2032)
9.1.5. Corneal stromal dystrophies
9.1.5.1. Market Revenue and Forecast (2019-2032)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Artificial Corneal Implants Market, By Implant Type
10.1. Artificial Corneal Implants Market, by Implant Type, 2023-2032
10.1.1. Synthetic
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Biosynthetic
10.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Artificial Corneal Implants Market, By Implant End-use
11.1. Artificial Corneal Implants Market, by Implant End-use, 2023-2032
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Ophthalmic Centers
11.1.2.1. Market Revenue and Forecast (2019-2032)
11.1.3. Ambulatory Surgical Centers
11.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Global Artificial Corneal Implants Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.1.2. Market Revenue and Forecast, by Indication (2019-2032)
12.1.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.1.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.1.5.2. Market Revenue and Forecast, by Indication (2019-2032)
12.1.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.1.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.1.6.2. Market Revenue and Forecast, by Indication (2019-2032)
12.1.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.1.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.2.2. Market Revenue and Forecast, by Indication (2019-2032)
12.2.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.2.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.2.5.2. Market Revenue and Forecast, by Indication (2019-2032)
12.2.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.2.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.2.6.2. Market Revenue and Forecast, by Indication (2019-2032)
12.2.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.2.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.2.7.2. Market Revenue and Forecast, by Indication (2019-2032)
12.2.7.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.2.7.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.2.8.2. Market Revenue and Forecast, by Indication (2019-2032)
12.2.8.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.2.8.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.3.2. Market Revenue and Forecast, by Indication (2019-2032)
12.3.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.3.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.3.5.2. Market Revenue and Forecast, by Indication (2019-2032)
12.3.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.3.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.3.6.2. Market Revenue and Forecast, by Indication (2019-2032)
12.3.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.3.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.3.7.2. Market Revenue and Forecast, by Indication (2019-2032)
12.3.7.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.3.7.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.3.8.2. Market Revenue and Forecast, by Indication (2019-2032)
12.3.8.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.3.8.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.4.2. Market Revenue and Forecast, by Indication (2019-2032)
12.4.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.4.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.4.5.2. Market Revenue and Forecast, by Indication (2019-2032)
12.4.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.4.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.4.6.2. Market Revenue and Forecast, by Indication (2019-2032)
12.4.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.4.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.4.7.2. Market Revenue and Forecast, by Indication (2019-2032)
12.4.7.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.4.7.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.4.8.2. Market Revenue and Forecast, by Indication (2019-2032)
12.4.8.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.4.8.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.5.2. Market Revenue and Forecast, by Indication (2019-2032)
12.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.5.5.2. Market Revenue and Forecast, by Indication (2019-2032)
12.5.5.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.5.5.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Transplant Type (2019-2032)
12.5.6.2. Market Revenue and Forecast, by Indication (2019-2032)
12.5.6.3. Market Revenue and Forecast, by Implant Type (2019-2032)
12.5.6.4. Market Revenue and Forecast, by Implant End-use (2019-2032)
Chapter 13. Company Profiles
13.1. FCI Ophthalmics, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Beijing Microkpro Medical Instrument Co. Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. DIOPTEX Medizinprodukte Forschungs
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. KeraMed, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. EyeYon
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168